Skip to content

Effect of lipid infusion during hemodialysis on renal recovery in patients with severe renal injury

Effect of pre-filter fatty acid infusion on clearance of protein bound uremic toxins in stage 3 AKI patients during HD and its impact on renal recovery- A randomized control study - Not Applicable

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/055983
Enrollment
78
Registered
2023-08-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N170- Acute kidney failure with tubularnecrosis

Interventions

Intervention1: Lipid Emulsion RRT: Intralipid�® 20% is a commonly used fat emulsion for parenteral nutrition, providing a source of calories and essential fatty acids. It is composed of 20% soybean

Sponsors

Indian Society of Nephrology Northern Zone
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Stage 3 AKI patients, due to acute tubular injury or acute interstitial nephritis 2. Initiated on RRT

Exclusion criteria

Exclusion criteria: 1. Patients with known hypersensitivity to egg, soybean, peanut protein, or to any of the active ingredients or excipients in Intralipid 20% 2. Patients with moderate-severe and severe hypertriglyceridemia (Triglycerides � 500mg/dL) 3. Patients with severe hemodynamic instability (�2 drugs for inotropic support) 4. Patients who are already on RRT before enrolment into the study 5. Patients with � 3+ dipstick proteinuria, RBC cast in urine (suggestive of glomerulonephritis)

Design outcomes

Primary

MeasureTime frame
Better reduction in serum Indoxyl Sulphate brought by protein bound toxin displacer-aided HD in comparison with conventional HDTimepoint: Serum Indoxyl sulphate levels will be measured before and after a dialysis session (after 2nd HD session, in particular). Samples are stored till adequate patients are recruited. These samples will then processed to compare the difference in decline of indoxyl sulphate between conventional HD and displacer aided HD

Secondary

MeasureTime frame
Better recovery of renal function in Indoxyl Sulphate brought by protein bound toxin displacer-aided HD groupTimepoint: 21 days from the day of initiation of HD

Countries

India

Contacts

Public ContactDr. Bhoobalan

AIIMS JODHPUR

bhoobalan.nephdoc@gmail.com7373422777

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026